Surgical Strategies for Recurrent Hepatocellular Carcinoma after Resection: A Review of Current Evidence.
Flavio MilanaMichela Anna PolidoroSimone FamularoAna LleoRenzo BoldoriniMatteo DonadonGuido TorzilliPublished in: Cancers (2023)
Hepatocellular carcinoma (HCC) is the most common primary liver cancer, and both liver resection and liver transplantation are considered potentially curative options. However, high recurrence rates affect the prognosis depending both on the primary HCC pathology characteristics or on the type and time of the relapse. While great attention has been usually posted on treatment algorithms for the first HCC, treatment algorithms for recurrent HCC (rHCC) are lacking. In these cases, surgery still represents a curative option with both redo hepatectomy and/or salvage liver transplantation, which are considered valid treatments in selected patients. In the current era of personalised medicine with promises of new systemic-targeted immuno-chemotherapies, we wished to perform a narrative review of the literature on the role of surgical strategies for rHCC.
Keyphrases
- machine learning
- prognostic factors
- end stage renal disease
- minimally invasive
- newly diagnosed
- ejection fraction
- chronic kidney disease
- deep learning
- rectal cancer
- heart failure
- working memory
- combination therapy
- peritoneal dialysis
- free survival
- drug delivery
- coronary artery bypass
- patient reported outcomes
- aortic valve replacement